← Apex Wire
Insider activity — BBTXBambusa Therapeutics, Inc.

5 Form 4 filings for BBTX between 2026-11-02 and 2026-11-03, from 5 filers. 4 discretionary (0 sales, 0 purchases), 1 routine grant or withholding filing. 3 of 5 carry a dollar total (3 stated, 0 computed as shares × price), summing to $58,639,957; a multi-transaction filing without a stated total contributes only its largest transaction, so the sum is a floor and the true figure is higher.

Filings 5 Filers 5 Discretionary 4 Routine 1 Structured 5/5

Filers
▸RA Capital Nexus Fund III, L.P.Director 2026-11-03 · converted (derivative) 3,144,858 for $46,639,957 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-03 converted (derivative) 3,144,858 — $46,639,957 6 RECEIPT ↗
▸Salvia Investment GmbH10% Owner 2026-11-02 · converted (derivative) 4,769,701 for $6,000,000 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-02 converted (derivative) 4,769,701 — $6,000,000 2 RECEIPT ↗
▸Jeggle Helmut WolfgangDirector 2026-11-02 · converted (derivative) 4,769,701 for $6,000,000 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-02 converted (derivative) 4,769,701 — $6,000,000 2 RECEIPT ↗
▸MiNeng, Inc.See remarks 2026-11-02 · converted (derivative) 147,238 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-02 converted (derivative) 147,238 — — 2 RECEIPT ↗
▸Xu ShanshanSee remarks 2026-11-02 · received (award/grant) 758,204 1 filing
FiledActionShares
largest txn
PriceFiling totalTxnsSEC
2026-11-02 received (award/grant) 758,204 — — 2 RECEIPT ↗

5 filers · 5 filings · disclosed filing totals sum to $58,639,957 (3/5 state one, 0 computed; totals are proceeds with a floor, never profit — a Form 4 states what was traded, not what it cost the filer)

Elsewhere